575 related articles for article (PubMed ID: 16831112)
21. Behavioural and pharmacological mechanisms of bupropion's anti-smoking effects: recent preclinical and clinical insights.
Paterson NE
Eur J Pharmacol; 2009 Jan; 603(1-3):1-11. PubMed ID: 19101536
[TBL] [Abstract][Full Text] [Related]
22. The use of bupropion hydrochloride for smoking cessation therapy.
Nichols MR
Clin Excell Nurse Pract; 1999 Nov; 3(6):317-22. PubMed ID: 10865568
[TBL] [Abstract][Full Text] [Related]
23. Bupropion-induced somnambulism.
Khazaal Y; Krenz S; Zullino DF
Addict Biol; 2003 Sep; 8(3):359-62. PubMed ID: 13129839
[TBL] [Abstract][Full Text] [Related]
24. Zyban: a new aid to smoking cessation treatment--will it work for psychiatric patients?
Farnam CR
J Psychosoc Nurs Ment Health Serv; 1999 Feb; 37(2):36-42; quiz 43-4. PubMed ID: 10023606
[TBL] [Abstract][Full Text] [Related]
25. A single-blind, randomized, crossover trial of the effects of a nicotine pouch on the relief of tobacco withdrawal symptoms and user satisfaction.
Thornley S; McRobbie H; Lin RB; Bullen C; Hajek P; Laugesen M; Senior H; Whittaker R
Nicotine Tob Res; 2009 Jun; 11(6):715-21. PubMed ID: 19454549
[TBL] [Abstract][Full Text] [Related]
26. The place of pharmacotherapy products in smoking cessation.
Percival J
Prof Nurse; 2003 Oct; 19(2):113-7. PubMed ID: 14593787
[TBL] [Abstract][Full Text] [Related]
27. Clinical efficacy of bupropion in the management of smoking cessation.
Jorenby D
Drugs; 2002; 62 Suppl 2():25-35. PubMed ID: 12109933
[TBL] [Abstract][Full Text] [Related]
28. Effect of sustained-release (SR) bupropion on craving and withdrawal in smokers deprived of cigarettes for 72 h.
Teneggi V; Tiffany ST; Squassante L; Milleri S; Ziviani L; Bye A
Psychopharmacology (Berl); 2005 Nov; 183(1):1-12. PubMed ID: 16160876
[TBL] [Abstract][Full Text] [Related]
29. Platelet monoamine oxidase, smoking cessation, and tobacco withdrawal symptoms.
Rose JE; Behm FM; Ramsey C; Ritchie JC
Nicotine Tob Res; 2001 Nov; 3(4):383-90. PubMed ID: 11694206
[TBL] [Abstract][Full Text] [Related]
30. Nicotine dependence, depression, and gender: characterizing phenotypes based on withdrawal discomfort, response to smoking, and ability to abstain.
Pomerleau OF; Pomerleau CS; Mehringer AM; Snedecor SM; Ninowski R; Sen A
Nicotine Tob Res; 2005 Feb; 7(1):91-102. PubMed ID: 15804681
[TBL] [Abstract][Full Text] [Related]
31. How does bupropion work as a smoking cessation aid?
Warner C; Shoaib M
Addict Biol; 2005 Sep; 10(3):219-31. PubMed ID: 16109583
[TBL] [Abstract][Full Text] [Related]
32. Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat.
Cryan JF; Bruijnzeel AW; Skjei KL; Markou A
Psychopharmacology (Berl); 2003 Jul; 168(3):347-58. PubMed ID: 12698231
[TBL] [Abstract][Full Text] [Related]
33. Bupropion for weight reduction.
Gadde KM; Xiong GL
Expert Rev Neurother; 2007 Jan; 7(1):17-24. PubMed ID: 17187492
[TBL] [Abstract][Full Text] [Related]
34. A randomized trial of bupropion and/or nicotine gum as maintenance treatment for preventing smoking relapse.
Covey LS; Glassman AH; Jiang H; Fried J; Masmela J; LoDuca C; Petkova E; Rodriguez K
Addiction; 2007 Aug; 102(8):1292-302. PubMed ID: 17624979
[TBL] [Abstract][Full Text] [Related]
35. Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt.
West R; Baker CL; Cappelleri JC; Bushmakin AG
Psychopharmacology (Berl); 2008 Apr; 197(3):371-7. PubMed ID: 18084743
[TBL] [Abstract][Full Text] [Related]
36. Sustained-release bupropion for hospital-based smoking cessation: a randomized trial.
Simon JA; Duncan C; Huggins J; Solkowitz S; Carmody TP
Nicotine Tob Res; 2009 Jun; 11(6):663-9. PubMed ID: 19395688
[TBL] [Abstract][Full Text] [Related]
37. Rodent models of nicotine withdrawal syndrome.
Malin DH; Goyarzu P
Handb Exp Pharmacol; 2009; (192):401-34. PubMed ID: 19184657
[TBL] [Abstract][Full Text] [Related]
38. [Zyban in smoking cessation--where is physician's ethic?].
Jacobsen CD
Tidsskr Nor Laegeforen; 2001 Jan; 121(1):107-8. PubMed ID: 12013602
[No Abstract] [Full Text] [Related]
39. Revealing the multidimensional framework of the Minnesota nicotine withdrawal scale.
Cappelleri JC; Bushmakin AG; Baker CL; Merikle E; Olufade AO; Gilbert DG
Curr Med Res Opin; 2005 May; 21(5):749-60. PubMed ID: 15969874
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of bupropion SR for smoking cessation: data from clinical trials and five years of postmarketing experience.
Ferry L; Johnston JA
Int J Clin Pract; 2003 Apr; 57(3):224-30. PubMed ID: 12723728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
